Skip to content

Achieve Life Sciences ACHV Total costs & expenses

Total costs & expenses at other companies

Forward Air logo
Forward AirFWRD
$561.61M-7.7%
Flotek Industries logo
Flotek IndustriesFTK
$7.95M+15.5%
AdaptHealth logo
AdaptHealthAHCO
$814.31M+7.9%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$104.13M+39.5%
Mannkind logo
MannkindMNKD
$91.84M+63.8%
OPT
Optimum Communications, Inc.OPTU
$4.43B+145%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's total costs & expenses?
Achieve Life Sciences (ACHV) reported total costs & expenses of $10.46M in Q1 2026.
How has Achieve Life Sciences's total costs & expenses changed year-over-year?
Achieve Life Sciences's total costs & expenses decreased by 18.9% year-over-year, from $12.89M to $10.46M.
What is the long-term trend for Achieve Life Sciences's total costs & expenses?
Over 4 years (2021 to 2025), Achieve Life Sciences's total costs & expenses has grown at a 13.5% compound annual growth rate (CAGR), from $33.09M to $54.88M.
What does total costs & expenses mean?
The aggregate of all operating and non-operating costs incurred by the company during the reporting period. This metric reflects the total financial resources consumed to support research, development, and general administrative activities. Monitoring this helps investors assess the company's overall burn rate and operational efficiency.